NASDAQ: HALO · Biotechnology
Over the past week, Halozyme Therapeutics (HALO) racked up 16 mentions across Reddit, X and news, and the read is an Adanos Buy. The crowd averages 81% bullish but is deeply split: News runs 100% bullish while X sits at just 62%. Wall Street is roughly in line with the crowd, with 7 of 9 analysts rating HALO a buy.
There is little buzz around HALO this week and little agreement on direction, which is why it reads as a Buy.
Wall Street’s 78% buy share sits next to a crowd that ranges from X at 62% to News at 100%. No other tracker puts the two side by side.
Across 9 analysts the consensus is a Strong Buy: 7 buy calls against 0 sell, with an average 12-month price target of $99.56.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is improving and the 2 sources disagree sharply, so the read is a Buy.
Wall Street’s 78% buy share lands almost exactly on the crowd average of 81%. The split is inside the crowd: News reads 100% bullish while X sits at 62%, a 38-point spread that single-source trackers miss.
Weekly price context: this Alpha Vantage chart keeps its own dated range; the sentiment metrics elsewhere on this page may be newer. Over the 30-day window, Halozyme Therapeutics (HALO) buzz held subdued around 36.9 while the price drifted up 8.1% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 2.2M shares. Updated Sep 26, 2026. Over the last 7 trading days, HALO gained 3.8%. Buzz activity in the recent week averaged 33.2 and was relatively stable, swinging between 21.7 and 39.6. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 15 of the 18 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Reddit data for this stock this week.
No Polymarket data for this stock this week.
Query sentiment for HALO and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live HALO sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 28, 2026.
| Adanos signal | Buy |
|---|---|
| Analyst consensus | Strong Buy (7 / 2 / 0) |
| Crowd bullish (7d) | 81% |
| Avg price target | $99.56 |
| Most bullish source | News, 100% |
| Most bearish source | X, 62% |
| Sentiment spread | 38 pts |
| Mentions (7d) | 16 |
| Market cap | $13.08B |
| P/E · Forward P/E | 33.0 · 11.5 |
| EPS · Beta | $3.49 · 0.9 |
| Revenue (TTM) | $1.66B · 25% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from X and News sources, Halozyme Therapeutics (HALO) currently carries an Adanos buy signal with 93/100 conviction. The current cross-source average reads 81% bullish across 2 active sources. Those sources contribute 16 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
The crowd reads bullish on Halozyme Therapeutics (HALO), averaging 81% bullish across 2 tracked sources over the last 7 days. The two ends of the range are News at 100% bullish and X at 62%, a 38-point spread. On the professional side, 7 of 9 analysts rate HALO a buy.
Of the 9 analysts covering Halozyme Therapeutics (HALO), 7 rate it a buy, 2 a hold and 0 a sell, for a strong buy consensus. The average price target is $99.56. That lines up with the crowd average of 81% bullish.
Halozyme Therapeutics (HALO)'s cross-source average is bullish at 81% bullish. All 2 tracked sources lean bullish. News reads 100% bullish and x coverage is the most negative at 62% bullish. The combined signal points to broad buy-side pressure with 93/100 conviction.
The cross-source average is bullish for Halozyme Therapeutics (HALO) at 81% bullish. All 2 tracked sources lean bullish. The most bearish reading is x at 62% bullish. 3-day activity momentum is rising across X and News. The buy signal carries 93/100 conviction.
X is the dominant discussion channel with 13 mentions (81% of total volume). News contributes 3 mentions. The cross-source average is bullish at 81% bullish, while x and news show rising 3-day activity. All 2 tracked sources lean bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. HALO's buy signal at 93/100 conviction reflects a bullish cross-source average at 81% bullish. All 2 tracked sources lean bullish. It is a research shortcut, not financial advice.
The HALO sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Buy signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key